Literature DB >> 9396870

Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography.

J Hiltunen1, K K Akerman, J T Kuikka, K A Bergström, C Halldin, T Nikula, P Räsänen, J Tiihonen, M Vauhkonen, J Karhu, J Kupila, E Länsimies, L Farde.   

Abstract

Iodine-123 labelled 2beta-carbomethoxy-3beta-(4-iodophenyl) (nor-beta-CIT) is an analogue of beta-CIT, which has high affinity to the serotonin transporter. Initial single-photon emission tomography (SPET) studies with [123I]nor-beta-CIT were performed in five healthy volunteers. In addition, its metabolism in plasma was investigated with gradient high performance liquid chromatography. [123I]nor-beta-CIT was prepared by a method which gave a specific radioactivity of more than 180 GBq/micromol. Unchanged [123I]nor-beta-CIT in plasma accounted for 43% and 19% of total radioactivity after 30 and 180 min, respectively. The dynamic SPET studies demonstrated a high and rapid uptake of radioactivity in the brain (6%/ID at 30 min). Highest accumulation was observed in the striatum, the mid-brain and the thalamus. The specific binding in the mid-brain was 33% higher compared with that of [123I]beta-CIT. The high radioactivity in the mid-brain is assumed to represent the accumulation of [123I]nor-beta-CIT in the serotonin transporter-rich regions, which indicates that [123I]nor-beta-CIT might be a potential tracer for visualization of serotonin transporter sites in the human brain with SPET.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9396870     DOI: 10.1007/s002590050189

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  SPECT imaging with the serotonin transporter radiotracer [123I]p ZIENT in nonhuman primate brain.

Authors:  Kelly P Cosgrove; Julie K Staley; Ronald M Baldwin; Frederic Bois; Christophe Plisson; Mohammed S Al-Tikriti; John P Seibyl; Mark M Goodman; Gilles D Tamagnan
Journal:  Nucl Med Biol       Date:  2010-05-06       Impact factor: 2.408

2.  SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder.

Authors:  Eduard Maron; Jyrki T Kuikka; Kai Ulst; Jari Tiihonen; Veiko Vasar; Jakov Shlik
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

Review 3.  Radiotracers for the Central Serotoninergic System.

Authors:  Reynald Mangeant; Emmanuelle Dubost; Thomas Cailly; Valérie Collot
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-03

Review 4.  5-HT radioligands for human brain imaging with PET and SPECT.

Authors:  Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen
Journal:  Med Res Rev       Date:  2011-06-14       Impact factor: 12.944

5.  Influence of serotonin transporter gene polymorphism (5-HTTLPR polymorphism) on the relation between brain 5-HT transporter binding and heart rate corrected cardiac repolarization interval.

Authors:  Esa Kauppila; Esko Vanninen; Salla Kaurijoki; Leila Karhunen; Kirsi H Pietiläinen; Aila Rissanen; Jari Tiihonen; Ullamari Pesonen; Jaakko Kaprio
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

6.  Elevated midbrain serotonin transporter availability in mixed mania: a case report.

Authors:  Tommi Tolmunen; Mikko Joensuu; Pirjo Irmeli Saarinen; Hanna Mussalo; Pasi Ahola; Ritva Vanninen; Jyrki Kuikka; Jari Tiihonen; Johannes Lehtonen
Journal:  BMC Psychiatry       Date:  2004-09-13       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.